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Vaginal infection therapy after premature rupture of the membranes
E. Saling, R. Zöckler
It is generally well-known in the literaturc that morbidity and
mortality due to infection rise with increased latency between pre-
mature rupture of the membranes and delivery. This emerges also
from an evaluation of WESSMANN and ZÖCKLER from our unit studying
all cases from 1968 up to June 1978 (Fig. 1).
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In accordance with the technique
of infection prophylaxis during
labor which we developed two
years ago (1), we now use this
new method modified accordingly
also in cases of premature rup-
ture of the membranes (2). All
patients in our prenatal care
unit are advised to come to the
hospital directly after the mem-
branes have ruptured. Immedi^
ately after admission a thin cathether is fixed onto the portio
with a knotted suture or it is inserted into the vagina by means
of a ring pessary onto which it is knotted with a silk thread (Fig.
2).
Through this cathether a
strongly diluted (0.5%)
PVP-iodine solution is
applied continuously into
the vagina. The speed of
the infusion is 20ml/h.
The infusion should always
be performed using an in-
fusion pump to exclude in-
terruptions in the flow.
This continuous disinfec-
tion of the lower birth
canal is performed until
the start of labor.
Naturally it is possible
to plug the cathether for
a short time - having first
applied a sufficient amount
of PVP-iodine, to enable
the patient to get up and
have a wash or to go to
the toilet.PVP-iodine-infusion 20mt/h
(0.5% PVP-iodine)
Results
Fig. 2
We have evaluated the infant morbidity and mortality caused by in-
fection äs being the most important clinical success criteria
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(Fig. 3) . In 81 premature infants
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Comparison of morbiditv and mortality of premature infants ( < 37/0 pregnancy weeks, birthweight
> 1000 g) in the newborn period ( 1—28 day of life) after early rupture of the membraneis (latency:
rupture- birth > 18 hours)
According to Salingand Zöckler.
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(<37/Oweeks of gest^tion)
that were born after a
latency time of more
than 18 hours after
early rupture of the
membranes and vagi
nal PVP-iodine the-
rapy, no infant died
äs a result of an
infection in the
whole neonatal
period (Ist to 28th
day of life). The
expected mortality
during the period
before the applica-
tion of PVP-iodine
lies in the region
of 6.5% (that is 5-
6 infants) in a com-
parable test group.
The mortality due to
other causes is
equally high in both groups, and also the middle latency time be-
tween rupture of the membranes and delivery.
The morbidity in infants caused by infection is only clearly lower
in the group where the PVP-iodine application was started within 4
hours after the membranes had ruptured.
Considering maternal puerperal morbidity we found in 4 cases out of
76 mothers (5.3%) of the 81 premature infants there was fever for
two days or longer. Among these were three caesareans; one of
these mothers died after twin pregnancy äs a result of clinically
supposed puerperal sepsis after having a long and feverish lying-
in period complicated by other illnesses (Diabetis, Parotitis and
suspected Multiple Sklerosis) . In consideration of the f act that
the membranes were intact during the last days before the caesarean,
that both infants showed no signs of intrauterine acquired infec-
tion and the histological examination of placentas, membranes and
umbilical cords gave no indication of any amnial infection, a
serious ascending infection before the caesarean had been performed
was supposed äs improbable.
Side-effects of iodine-resorption
In our collective with subpartum infeetion prophylaxis we had ob-
served that on the 5th day of life a considerable number of these
newborn had increased TSH-screening levels (3) . The reason for
this is an iodine-resorption of the fetus mainly through the
scalp. After early rupture of the membranes and PVP-iodine prophy-
laxis, the fetus is not directly exposed to the PVP-iodine solution.
However vaginal iodine-resorption cän occur through the mother,
which can also lead to an iodine increase in the fetal blood. In
several cases of early rupture of the membranes we found some con-
siderable TSH-increase in the umbilical cord blood. However in all
cases this was only a temporary increase lasting for a few days,
exactly like the TSH-increase after subpartum usage of PVP-iodine,
so that the TSH-screening levels in all these newborn returned to
normal on the 5th or at the latest 7th day of life.
Due to the possibility of iodine resorption occurring through the
mother all pregnant women should be excluded from this therapy who
have had thyroid illness in the past.
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